FDA Accepts Apotex’s Neupogen Biosimilar Application: Raises Issues of How the Agency Will Address Exclusivity, Previous Warning Letters to Apotex Read more
AstraZeneca Pays $7.9 Million To Resolve Kickback Allegations Related to PBM Formulary Placement Read more
Sunshine Briefing Features Calls for Expansion of Reporting Requirements and An End To Drug Reps and Samples Read more
AdvaMed Releases Innovation Agenda: Proposes Device Tax Repeal; Automatic Coverage of FDA-Approved Clinical Trials Read more
CMS Issues Final Rule on Managing Conflicts of Interests in Medicare Prescription Drug Decisions Read more
FDA Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Human Prescription Drugs Read more